Killer virus Marburg which has a 50% death rate is suspected to have arrived in Europe

Europe is on alert as the deadly Marburg virus, with a 50% death rate, has potentially made its way onto the continent. The virus has claimed the lives of nine individuals, sparking concern across the region. The first suspected cases were detected in Europe when a 26-year-old medical student and his girlfriend fell ill with symptoms of the lethal virus at Hamburg train station after returning from Rwanda. Emergency response teams, donned in protective gear, quickly responded by evacuating passengers from a train from Frankfurt, where the couple had exhibited flu-like symptoms.

The situation led to a temporary closure of part of the train station as health authorities conducted thorough investigations. One of the suspected Marburg patients reported mild vomiting and sought help from emergency services, prompting a swift response from the Hamburg Fire Department. Concerns were raised as the student had been in contact with a confirmed Marburg patient in Rwanda, underlining the potential exposure risks associated with the virus.

Marburg virus, which can have a fatality rate as high as 88%, belongs to the same family as Ebola. The World Health Organization (WHO) notes that the average fatality rate for Marburg is around 50%. Symptoms of the virus include a sudden high fever, severe headache, vomiting, diarrhoea, and uncontrolled bleeding. The infected student and his girlfriend were admitted to Eppendorf University Hospital, specialised in tropical diseases, while their belongings were confiscated for examination.

Although there are currently no approved vaccines or treatments for Marburg, promising candidates are being developed and may soon undergo trials. Non-profit organisations such as the Sabin Vaccine Institute and the International AIDS Vaccine Initiative (IAVI) are collaborating with health authorities to address the outbreak. Early medical attention and rehydration are advised by the WHO to potentially enhance survival rates for individuals infected with this devastating illness.

The suspected cases in Europe have raised concerns about the spread of the Marburg virus and highlighted the importance of swift and effective response measures to contain and mitigate its impact. As health authorities continue to monitor the situation, efforts are underway to develop preventive measures and treatments to combat the virus effectively.

The potential presence of the Marburg virus in Europe serves as a stark reminder of the ongoing global health challenges posed by infectious diseases and the critical importance of international cooperation in addressing such threats. As investigations and response efforts continue, health authorities are working diligently to safeguard public health and prevent further spread of the virus.